Medulloblastoma
📧 Sign up to get email alerts when something new happens for Medulloblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Methionine PET/CT Studies In Patients With Cancer [Phase 2]
Phase 2 methionine-based PET/CT imaging studies in patients with various cancers; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation
A clinical trial update describing long-term follow-up of medulloblastoma survivors who received craniospinal irradiation; the study is curr…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study [Phase 2]
Phase 2 clinical trial update examining quantitative measures of radiation-induced neuroinflammation in brain tumor and medulloblastoma; the…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors
This trial update describes a pediatric brain tumor study using cerebrospinal fluid cell-free tumor DNA; the study was terminated.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma [NA]
The document reports a clinical trial update for an individualized treatment plan in children and young adults with relapsed medulloblastoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Lutathera (177Lu-DOTATATE) in combination with Olaparib for somatostatin receptor–expressing recurrent…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Lutathera (lutetium-177 dotatate) for recurrent or progressive high-grade central nervous system tumor…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors [Phase 1]
Phase 1 trial updating the investigation of HSV-1 G207 for children with recurrent or refractory cerebellar brain tumors; the study is curre…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) [Phase 2]
This update reports on a Phase 2 pediatric MATCH trial evaluating ensartinib for patients with relapsed or refractory ALK- or ROS1-genomic a…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
This registry study collects data on relapsed and progressive medulloblastoma driven by Sonic Hedgehog (SHH) pathway activation, including t…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma [Phase 1]
Phase 1 trial of pembrolizumab in pediatric patients with recurrent or refractory high-grade gliomas, including diffuse intrinsic pontine gl…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults [NA]
Overview of the my.naviGATE guide for after-treatment effects in adolescents and young adults with sarcoma and related cancers; the study is…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma [Phase 2]
Phase 2 clinical trial of the PEP-CMV CMV antigen-targeted vaccine for newly diagnosed pediatric high-grade glioma, diffuse intrinsic pontin…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma [Phase 1]
A Phase 1 pediatric trial of SurVaxM for progressive or relapsed medulloblastoma, high-grade glioma, ependymoma, and newly diagnosed diffuse…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) [Phase 1]
Phase 1 clinical trial evaluating RNA-lipid particle vaccines for recurrent or progressive medulloblastoma; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications [Phase 1, Phase 2]
Clinical trial update for PLX038 in primary CNS tumors with MYC or MYCN amplification; Phase 1/2 studies are currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) [Phase 1]
This clinical trial update describes an ongoing Phase 1 study evaluating adoptive cellular therapy immunotherapy for several pediatric malig…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma [Phase 1, Phase 2]
This clinical trial update describes a phase 1/2 study of PEP-CMV in combination with nivolumab for newly diagnosed and recurrent diffuse mi…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma [Phase 1]
Phase 1 clinical trial evaluating IL13Ralpha2-CAR T cells for treating leptomeningeal metastasis, glioblastoma, ependymoma, and medulloblast…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma [Phase 2]
Phase 2 clinical trial evaluating DFMO as maintenance therapy for molecular high/very high risk and relapsed medulloblastoma is currently re…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation [EARLY_Phase 1]
This is a pediatric early-phase 1 trial update evaluating intrathecal topotecan with maintenance chemotherapy for high-risk embryonal centra…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss [Phase 3]
A Phase 3 clinical trial is recruiting to evaluate sodium thiosulfate for reducing hearing loss in children with medulloblastoma.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors [Phase 2]
A Phase 2 clinical trial update describes an antiangiogenic therapy for children with recurrent medulloblastoma, ependymoma, ATRT, and other…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma [Phase 2]
A Phase 2 clinical trial investigating reduced craniospinal radiation therapy and chemotherapy for younger patients with newly diagnosed WNT…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma [Phase 2]
This is a Phase 2 clinical trial update from St. Jude investigating molecular and clinical risk-directed therapy for newly diagnosed medullo…